Opioid Bowel Dysfunction and Narcotic Bowel Syndrome: A Population-Based Study

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Gastroenterology

• Publication date

  2009-04-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ajg.2009.71PMID 19367263PMCID PMC3209714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Opioid-Induced Bowel Dysfunction

  2012cited by this paper
• Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments.

  2008cited by this paper
• Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden

  2007cited by this paper
• The narcotic bowel syndrome: clinical features, pathophysiology, and management.

  2007cited by this paper
• Opioid-Induced Gastrointestinal Dysfunction

  2006cited by this paper
• Oral Methadone for Chronic Noncancer Pain: A Systematic Literature Review of Reasons for Administration, Prescription Patterns, Effectiveness, and Side Effects

  2005cited by this paper
• Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids

  2005cited by this paper
• Opioids in chronic non‐cancer pain: systematic review of efficacy and safety

  2004cited by this paper
• An evaluation of the care provided to patients prescribed controlled substances for chronic nonmalignant pain at an academic family medicine center.

  2004cited by this paper
• A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia.

  2004cited by this paper
• Opioid Antagonists in the Treatment of Opioid-Induced Constipation and Pruritus

  2001cited by this paper
• Symptoms during cancer pain treatment following WHO‐guidelines: a longitudinal follow‐up study of symptom prevalence, severity and etiology

  2001cited by this paper
• Incidence, prevalence, and management of opioid bowel dysfunction.

  2001cited by this paper
• Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities

  2000cited by this paper
• Opioid-induced emesis among hospitalized nonsurgical patients: effect on pain and quality of life.

  1999cited by this paper
• The threat to medical-records research.

  1997cited by this paper
• History of the Rochester Epidemiology Project.

  1996cited by this paper
• Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee.

  1995cited by this paper
• Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization.

  1995cited by this paper
• Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic.

  1994cited by this paper
• A case of narcotic bowel syndrome successfully treated with clonidine.

  1994cited by this paper
• A bowel symptom questionnaire for the elderly.

  1992cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

  1992cited by this paper
• Epidemiology of colonic symptoms and the irritable bowel syndrome.

  1991cited by this paper
• The incidence of narcotic-induced emesis.

  1991cited by this paper
• A patient questionnaire to identify bowel disease.

  1989cited by this paper
• The narcotic bowel syndrome.

  1989cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• Narcotic bowel syndrome treated with clonidine. Resolution of abdominal pain and intestinal pseudo-obstruction.

  1984cited by this paper
• Psychometric properties of the SUNYA revision of the psychosomatic symptom checklist

  1984cited by this paper
• GASTROENTEROLOGY 2006;130:1492–1497 Functional Abdominal Pain Syndrome

  year unknowncited by this paper

• Jejunal feeding in patients with disorders of gut–brain interaction and gastrointestinal dysmotility: perceptions among health professionals

  2026cites this paper
• Practical management of the patient with a centrally mediated disorder of gastrointestinal pain

  2025cites this paper
• The Impact of Antispasmodic Use on Abdominal Pain and Opioid Use in Inflammatory Bowel Disease: A Population‐Based Study

  2025cites this paper
• Prescription pain medications for disorders of gut–brain interaction: Comparing usage patterns with clinical practice recommendations

  2023cites this paper
• Opioid-induced bowel dysfunction: a literature review

  2023cites this paper
• Less Well-Known Consequences of the Long-Term Use of Opioid Analgesics: A Comprehensive Literature Review

  2022cites this paper
• Less Well-Known Consequences of the Long-Term Use of Opioid Analgesics: A Comprehensive Literature Review

  2022cites this paper
• Acupuncture as a Complementary Therapy for Cancer-Induced Bone Pain: A Systematic Review and Meta-Analysis

  2022cites this paper
• Opioid-related emergency department visits and hospitalizations among patients with chronic gastrointestinal symptoms and disorders dually enrolled in the Department of Veterans Affairs and Medicare Part D.

  2021cites this paper
• Medical marijuana for inflammatory bowel disease: the highs and lows

  2021cites this paper
• Increasing Rates of Opioid Prescriptions for Gastrointestinal Diseases in the United States.

  2020cites this paper
• The management of adult patients with severe chronic small intestinal dysmotility

  2020cites this paper
• Opioid-induced bowel disorder and narcotic bowel syndrome

  2020cites this paper
• [Emerging Issues in Esophageal Motility Diseases].

  2019cites this paper
• Evaluation of Patients with Suspected Gastroparesis.

  2019cites this paper
• Characterization of Upper Gastrointestinal Symptoms, Gastric Motor Functions, and Associations in Patients with Diabetes at a Referral Center

  2019cites this paper
• Abdominal pain in opiate addicted patients and other industrial opiates in moddaress hospital 2017-2018

  2019cites this paper
• Implications of the Opioid Epidemic for the Clinical Gastroenterology Practice

  2019cites this paper
• Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain

  2018cites this paper
• Reduction in pain: Is it worth the gain? The effect of opioids on the GI tract

  2018cites this paper
• Opioid-Induced Esophageal Dysfunction: An Emerging Entity with Sweeping Consequences

  2018cites this paper
• Strategies to Identify and Reduce Opioid Misuse Among Patients with Gastrointestinal Disorders: A Systematic Scoping Review

  2017cites this paper
• Functional Dyspepsia: Advances in Diagnosis and Therapy

  2017cites this paper
• Predictors of Chronic Opioid Use in Newly Diagnosed Crohn's Disease

  2017cites this paper
• Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits

  2017cites this paper
• Narcotic bowel syndrome.

  2017cites this paper
• The Epidemiology of Chronic Abdominal Pain

  2015cites this paper
• Evolving paradigms in the treatment of opioid-induced bowel dysfunction

  2015cites this paper
• Avoiding analgesic escalation and excessive healthcare utilization in severe irritable bowel syndrome: a role for intramuscular anticholinergics?

  2014cites this paper
• Narcotic Bowel Syndrome and Opioid-Induced Constipation

  2014cites this paper
• The Prevalence and Predictors of Opioid Use in Inflammatory Bowel Disease: A Population-Based Analysis

  2014cites this paper
• The narcotic bowel syndrome: a recent update.

  2014cites this paper
• A Review of the Clinical Manifestations, Pathophysiology and Management of Opioid Bowel Dysfunction and Narcotic Bowel Syndrome

  2014cites this paper
• Diagnosis and treatment of narcotic bowel syndrome

  2014cites this paper
• Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction

  2014cites this paper
• Prevalence of Narcotic Bowel Syndrome in Opioid Abusers in Iran

  2014cites this paper
• Prevalencia y severidad de la disfunción intestinal inducida por opioides☆

  2013cites this paper
• Mise au point sur la méthylnaltrexone dans la constipation induite par les opioïdes et cas d'observation de la tolérance du médicament au CHU de Grenoble

  2013cites this paper
• The Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A Review

  2013cites this paper
• Associations between medication use and functional gastrointestinal disorders: a population‐based study

  2013cites this paper
• Opioid-Induced Bowel Dysfunction

  2012cites this paper
• Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?

  2012cites this paper
• Drug Management of Visceral Pain: Concepts from Basic Research

  2012cites this paper
• Narcotic bowel syndrome.

  2012cites this paper
• Effects of methylnaltrexone in patients with narcotic bowel syndrome: a pilot observational study

  2012cites this paper
• The 'mystery' of opioid-induced diarrhea.

  2011cites this paper
• PEGAFERON IN HEPATITIS C: RESULTS OF A MULTICENTER STUDY

  2010cites this paper
• Opioid antagonists for prevention and treatment of opioid-induced gastrointestinal effects

  2010cites this paper
• Opioid‐induced bowel disorders and narcotic bowel syndrome in patients with chronic non‐cancer pain

  2010cites this paper
• Evidence of central and peripheral sensitization in a rat model of narcotic bowel-like syndrome.

  2010cites this paper
• Chapter 8 - Opioid analgesics and narcotic antagonists

  2009cites this paper